Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 252

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 8
Chunk 252
---
Item 8. Financial Information

  Consolidated Statements and Other Financial Information  
 ───────────────────────────────────────────────────────────

Consolidated Financial Statements

See Item 18. “Financial
Statements.”

Legal and Arbitration Proceedings

From time to time, we may
be subject to various legal proceedings and claims that arise in the ordinary course of business, as well as governmental and other regulatory
investigations and proceedings. Although the outcome of the various legal proceedings and claims cannot be predicted with certainty, we
are not currently a party to any legal proceedings that, if determined adversely to us, would, in our opinion, likely have a significant
effect on our financial position or profitability. For more information regarding risks related to litigation, see “ Risk Factors-Risks
Related to Our Business and Industry-Third parties may initiate legal proceedings alleging that we are infringing, misappropriating or
otherwise violating their intellectual property rights, the outcome of which would be uncertain. Defending against such lawsuits will
be costly and time consuming, and an unfavorable outcome in that litigation would have a material adverse effect on our business.

Dividend Policy

We do not anticipate paying
any dividends in the foreseeable future. We currently intend to retain future earnings, if any, to finance operations and expand our business.
Our board of directors has sole discretion whether to pay dividends. If our board of directors decides to pay dividends, the form, frequency
and amount will depend upon our future operations and earnings, capital requirements and surplus, general financial condition, contractual
restrictions and other factors that our directors may deem relevant.

For the years ended December
31, 2024, 2023, 2022, 2021 and 2020, we did not pay any dividends.

The Companies Law imposes
restrictions on our ability to declare and pay dividends. See “Dividend and Liquidation Rights” in Exhibit 2.1 to this
Annual Report for additional information. See also “ Item 3. D. Risk Factors-Risks Related to Our Class A Ordinary Shares-We do
not intend to pay dividends for the foreseeable future. Accordingly, you may not receive any return on investment unless you sell your
ordinary shares for a price greater than the price you paid for such shares.

Payment of dividends may be
subject to Israeli withholding taxes. See “ Israeli Tax Considerations” for additional information.

  Significant Changes  
 ───────────────────────

None.

Item 9. The Offer and Listing